Literature DB >> 23239779

Uterine perforation during intracavitary brachytherapy for carcinoma of the cervix.

Girish Sadam Prabhakar1, Swaroop Revannasiddaiah, Sridhar Papaiah Susheela, Surega Anbumani.   

Abstract

Entities:  

Mesh：

Year:  2012        PMID： 23239779      PMCID： PMC4545002          DOI： 10.1136/bcr-2012-007830

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN： 1757-790X


× No keyword cloud information.
  3 in total

1.  CT scanning in intracavitary therapy: unexpected findings in "straightforward" insertions.

Authors:  W P Makin; R D Hunter
Journal:  Radiother Oncol       Date:  1988-12       Impact factor: 6.280

2.  Prospective comparison of clinical and computed tomography assessment in detecting uterine perforation with intracavitary brachytherapy for carcinoma of the cervix.

Authors:  E A Barnes; G Thomas; I Ackerman; L Barbera; D Letourneau; K Lam; N Makhani; R Sankreacha
Journal:  Int J Gynecol Cancer       Date:  2007-03-13       Impact factor: 3.437

3.  Optimization of high-dose-rate cervix brachytherapy applicator placement: the benefits of intraoperative ultrasound guidance.

Authors:  Melanie T M Davidson; Jasper Yuen; David P D'Souza; John S Radwan; J Alex Hammond; Deidre L Batchelar
Journal:  Brachytherapy       Date:  2008 Jul-Sep       Impact factor: 2.362
  3 in total
  2 in total

1.  Uterine perforation and its dosimetric implications in cervical cancer high-dose-rate brachytherapy.

Authors:  Yasir A Bahadur; Maha M Eltaher; Ashraf H Hassouna; Mohammad A Attar; Camelia Constantinescu
Journal:  J Contemp Brachytherapy       Date:  2015-02-04

2.  Clinical and dosimetric consequences of imperfect applicator insertion in cervical cancer brachytherapy.

Authors:  Bikramjit Chakrabarti; Suparna Kanti Pal; Harris Mahammad Sepai; Somapriya Basu Roy; Sanjay Kr Kar; Annesha Lahiri; Sounik Das; Amit Bala
Journal:  J Contemp Brachytherapy       Date:  2018-08-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.